- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Volume 2013 (2013), Article ID 603129, 8 pages
A New Fluorescence-Based Reporter Gene Vector as a Tool for Analyzing and Fishing Cells with Activated Wnt Signaling Pathway
University of Applied Science Kaiserslautern, 66482 Zweibrücken, Germany
Received 26 June 2013; Accepted 28 July 2013
Academic Editors: P. Clavère, M. Loizidou, and D. Peng
Copyright © 2013 Johanna Apfel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- P. Polakis, “The many ways of Wnt in cancer,” Current Opinion in Genetics and Development, vol. 17, no. 1, pp. 45–51, 2007.
- K. W. Kinzler and B. Vogelstein, “Lessons from hereditary colorectal cancer,” Cell, vol. 87, no. 2, pp. 159–170, 1996.
- B. T. MacDonald, K. Tamai, and X. He, “Wnt/β-catenin Signaling: components, mechanisms, and diseases,” Developmental Cell, vol. 17, no. 1, pp. 9–26, 2009.
- J. R. Miller and R. T. Moon, “Signal transduction through β-catenin and specification of cell fate during embryogenesis,” Genes and Development, vol. 10, no. 20, pp. 2527–2539, 1996.
- B. Lustig and J. Behrens, “The Wnt signaling pathway and its role in tumor development,” Journal of Cancer Research and Clinical Oncology, vol. 129, no. 4, pp. 199–221, 2003.
- T. Kiesslich, B. Alinger, G. W. Wolkersdörfer, M. Ocker, D. Neureiter, and F. Berr, “Active Wnt signalling is associated with low differentiation and high proliferation in human biliary tract cancer in vitro and in vivo and is sensitive to pharmacological inhibition,” International Journal of Oncology, vol. 36, no. 1, pp. 49–58, 2010.
- D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011.
- F. Hollande, J. Pannequin, and D. Joubert, “The long road to colorectal cancer therapy: searching for the right signals,” Drug Resistance Updates, vol. 13, no. 1-2, pp. 44–56, 2010.
- S. Tommasi, R. Pinto, B. Pilato, and A. Paradiso, “Molecular pathways and related target therapies in liver carcinoma,” Current Pharmaceutical Design, vol. 13, no. 32, pp. 3279–3287, 2007.
- F. Verkaar and G. J. R. Zaman, “New avenues to target Wnt/β-catenin signaling,” Drug Discovery Today, vol. 16, no. 1-2, pp. 35–41, 2011.
- V. Korinek, N. Barker, P. J. Morin et al., “Constitutive transcriptional activation by a β-catenin-Tcf complex in APC(-/-) colon carcinoma,” Science, vol. 275, no. 5307, pp. 1784–1787, 1997.
- Y. J. Kang, H. J. Park, H. J. Chung et al., “Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells,” Molecular Pharmacology, vol. 82, no. 2, pp. 168–177, 2012.
- C. Fuerer and R. Nusse, “Lentiviral vectors to probe and manipulate the Wnt signaling pathway,” PLoS ONE, vol. 5, no. 2, Article ID e9370, 2010.
- M. Zhang, R. L. Atkinson, and J. M. Rosen, “Selective targeting of radiation-resistant tumor-initiating cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 8, pp. 3522–3527, 2010.
- D. Horst, J. Chen, T. Morikawa, S. Ogino, T. Kirchner, and R. A. Shivdasani, “Differential WNT activity in colorectal cancer confers limited tumorigenic potential and is regulated by MAPK signaling,” Cancer Research, vol. 72, no. 6, pp. 1547–1556, 2012.
- E. M. Wexler, A. Paucer, H. I. Kornblum, T. D. Plamer, and D. H. Geschwind, “Endogenous Wnt signaling maintains neural progenitor cell potency,” Stem Cells, vol. 27, no. 5, pp. 1130–1141, 2009.
- N. Currier, K. Chea, M. Hlavacova, D. J. Sussman, D. C. Seldin, and I. Dominguez, “Dynamic expression of a LEF-EGFP WNT reporter in mouse development and cancer,” Genesis, vol. 48, no. 3, pp. 183–194, 2010.
- A. C. Rios, N. Denans, and C. Marcelle, “Real-time observation of Wnt β-catenin signaling in the chick embryo,” Developmental Dynamics, vol. 239, no. 1, pp. 346–353, 2010.
- T. L. Biechele, A. M. Adams, and R. T. Moon, “Transcription-based reporters of Wnt/β-catenin signaling,” Cold Spring Harbor Protocols, vol. 4, no. 6, 2009.
- A. Hiyama, D. Sakai, F. Arai, D. Nakajima, K. Yokoyama, and J. Mochida, “Effects of a glycogen synthase kinase-3β inhibitor (LiCl) on c-myc protein in intervertebral disc cells,” Journal of Cellular Biochemistry, vol. 112, no. 10, pp. 2974–2986, 2011.
- L. Ring, I. Peröbner, M. Karow, M. Jochum, P. Neth, and A. Faussner, “Reporter gene HEK 293 cells and WNT/Frizzled fusion proteins as tools to study WNT signaling pathways,” Biological Chemistry, vol. 392, no. 11, pp. 1011–1020, 2011.
- S. Sievers, C. Fritzsch, M. Grzegorczyk, C. Kuhnen, and O. Müller, “Absolute β-catenin concentrations in Wnt pathway-stimulated and non-stimulated cells,” Biomarkers, vol. 11, no. 3, pp. 270–278, 2006.
- B. Schmitz, A. Radbruch, T. Kummel et al., “Magnetic activated cell sorting (MACS)—a new immunomagnetic method for megakaryocytic cell isolation: comparison of different separation techniques,” European Journal of Haematology, vol. 52, no. 5, pp. 267–275, 1994.
- J. C. Wu, P. Y. Tseng, W. S. Tsai et al., “Antibody conjugated supported lipid bilayer for capturing and purification of viable tumor cells in blood for subsequent cell culture,” Biomaterials, vol. 34, no. 21, pp. 5191–5199, 2013.
- J. Willert, M. Epping, J. R. Pollack, P. O. Brown, and R. Nusse, “A transcriptional response to Wnt protein in human embryonic carcinoma cells,” BMC Developmental Biology, vol. 2, no. 1, p. 8, 2002.
- M. E. Conacci-Sorrell, T. Ben-Yedidia, M. Shtutman, E. Feinstein, P. Einat, and A. Ben-Ze'ev, “Nr-CAM is a target gene of the β-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis,” Genes and Development, vol. 16, no. 16, pp. 2058–2072, 2002.
- V. J. M. Wielenga, R. Smits, V. Korinek et al., “Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway,” American Journal of Pathology, vol. 154, no. 2, pp. 515–523, 1999.